SABA inhaler carbon emissions drop by one-third 

NHS England data has shown that average emissions for short-acting beta-2 agonist (SABA) inhalers prescribed in primary care declined by 33% between 2020 and November 2024 — from 24.2 kgCO2e to 16.1 kgCO2e. The Pharmaceutical Journal reports that this fall in SABA inhaler emissions most likely owes to patients switching from the Ventolin Evohaler to the Salamol inhaler.

NICE has produced a decision aid on asthma inhalers and climate change. It explains the options for patients thinking about reducing the carbon footprint of their asthma treatment and the options available.

Find our more…